Geoffrey L Greene

Overcoming mutation-based resistance to antiandrogens with rational drug design

V. Arora, C. Sawyers, G. Greene, 2013, eLife.

Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation

Sarat Chandarlapaty, Emad Tajkhorshid, Patrick R Griffin, 2016, eLife.

Label-free detection of protein-protein interactions on biochips.

Milan Mrksich, Robert W. Hsieh, M. Mrksich, 2005, Angewandte Chemie.

Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance

Sarat Chandarlapaty, Christopher G Mayne, B. Katzenellenbogen, 2018, Nature Reviews Cancer.

MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11

Charles M Perou, Dezheng Huo, Olufunmilayo I Olopade, 2013, Nature Communications.

Ligand control of coregulator recruitment to nuclear receptors.

Kendall W Nettles, K. Nettles, G. Greene, 2005, Annual review of physiology.